← Volver a la portada
Estados Unidos · Revistas de economía · Fortune

Fed up with the healthcare industry, this red state capped insulin prices for patients

Publicado por Fortune · Estados Unidos hace 1 h
A mother and daughter stand together for a portrait on their farm
A mother and daughter stand together for a portrait on their farm · Fortune

Resumen detallado

The Kritzbergers also pay a lot out-of-pocket every year for medical care, despite having insurance — at least $8,000 for drugs, supplies, and medical appointments.

The Kritzberger family has farmed in the Red River Valley for more than a century. They once had livestock. Now they grow sugar beets, soybeans, and grains.

Like many farmers, they labor to balance the books. “We’re in an incredible amount of debt,” Ang Kritzberger said as she walked the farm on a recent fall morning.

For the past 10 years, the Kritzbergers have had another worry. Their daughter Nina has Type 1 diabetes. That’s landed the family in a national debate about how to protect patients from high insulin costs.

“I slept by her bedside for the first 60 days,” Ang Kritzberger said. “And I had to stick her finger every two hours, 24 hours a day, to make sure that she was OK.”

The Kritzbergers also pay a lot out-of-pocket every year for medical care, despite having insurance — at least $8,000 for drugs, supplies, and medical appointments.

That’s not uncommon. Soaring insulin prices for years forced people with diabetes to pay hundreds, even thousands, of dollars. Many rationed insulin, with sometimes deadly consequences.

But today, there’s a growing movement across the country to cap what people with diabetes pay for insulin. That’s brought together Democrats and Republicans, tapping an emerging consensus that the government should protect people from high drug prices.

“Typically, Republicans are more on the free-market side of things, Democrats are more supportive of intervening,” said North Dakota state Sen. Sean Cleary, a Republican. “But in this case, I think there was broad-enough agreement that this market just wasn’t functioning for folks.”

Cleary co-sponsored legislation last year to cap patients’ insulin bills at $25 a month. North Dakota is one of 29 states that have enacted such measures.

Inicio del artículo, extracto de Fortune. Para leer el resto, abra el artículo en el sitio del medio.

Leer el artículo completo en Fortune Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (fortune.com)

También te puede interesar